10-Q Filing

BNB PLUS CORP. CIK: 744452 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-061577`
Period End Date	20200331
Filing Date	20200514
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	apdn-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 72 Cash Flow Statement 73 Stockholders Equity 33

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.50K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.50K	USD	Point-in-time
Accounts payable and accrued liabilities, related parties (in dollars)	`AccountsPayableRelatedPartiesCurrentAndNoncurrent`	$40.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$558.99K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.66M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net of allowance of $4,500 at March 31, 2020 and September 30, 2019, respectively	`AccountsReceivableNetCurrent`	$839.95K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Accounts receivable, net of allowance of $4,500 at March 31, 2020 and September 30, 2019, respectively	`AccountsReceivableNetCurrent`	$549.12K	USD	Point-in-time
Inventories	`InventoryNet`	$88.94K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$142.63K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$678.12K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$604.74K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.98M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.15M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$226.22K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$265.40K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.06M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Deferred offering costs	`DeferredCosts`	$109.70K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$62.35K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$76.08K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$720.95K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$734.77K	USD	Point-in-time
Total Assets	`Assets`	$3.56M	USD	Point-in-time
Total Assets	`Assets`	$11.33M	USD	Point-in-time
Accounts payable and accrued liabilities (including related party of $40,000 at March 31, 2020)	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.62M	USD	Point-in-time
Accounts payable and accrued liabilities (including related party of $40,000 at March 31, 2020)	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.18M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$671.53K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$628.99K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.85M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$722.56K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$621.97K	USD	Point-in-time
Secured convertible notes payable, related party. net of debt issuance costs	`ConvertibleLongTermNotesPayable`	$1.44M	USD	Point-in-time
Secured convertible notes payable, related party. net of debt issuance costs	`ConvertibleLongTermNotesPayable`	$1.49M	USD	Point-in-time
Secured convertible notes payable, recorded at fair value	`SecuredConvertibleNotesPayableNoncurrentFairValueDisclosures`	$102.78K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.06M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 4,059,943 and 1,207,993 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	`CommonStockValue`	$1.21K	USD	Point-in-time
Common stock, par value $0.001 per share; 500,000,000 shares authorized; 4,059,943 and 1,207,993 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	`CommonStockValue`	$4.06K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$269.69M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$255.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-262.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-256.81M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity (deficit):	`StockholdersEquity`	$7.27M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity (deficit):	`StockholdersEquity`	$-841.46K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-5.85K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-7.04K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-734.36K	USD	Point-in-time
Total liabilities and equity (deficit)	`LiabilitiesAndStockholdersEquity`	$3.56M	USD	Point-in-time
Total liabilities and equity (deficit)	`LiabilitiesAndStockholdersEquity`	$11.33M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Interest (expense) income, related party interest	`InterestIncomeRelatedParty`	$49.31K	USD	2 Qtrs
Interest (expense) income, related party interest	`InterestIncomeRelatedParty`	$25.84K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$778.47K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.66M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.19M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$552.47K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$286.63K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$133.14K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$179.58K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$411.61K	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.66M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.61M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.53M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.29M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.27M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$703.02K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$651.38K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.36M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$97.67K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$141.60K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$66.54K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$232.72K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.28M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.20M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$6.07M	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-5.29M	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-5.83M	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.63M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.68M	USD	1 Quarter
Interest expense (including related parties interest of $25,840 and $49,310 for the three and six months ended March 31, 2019, respectively)	`InterestIncomeExpenseNet`	$-37.42K	USD	1 Quarter
Interest expense (including related parties interest of $25,840 and $49,310 for the three and six months ended March 31, 2019, respectively)	`InterestIncomeExpenseNet`	$-29.10K	USD	1 Quarter
Interest expense (including related parties interest of $25,840 and $49,310 for the three and six months ended March 31, 2019, respectively)	`InterestIncomeExpenseNet`	$-58.19K	USD	2 Qtrs
Interest expense (including related parties interest of $25,840 and $49,310 for the three and six months ended March 31, 2019, respectively)	`InterestIncomeExpenseNet`	$-69.03K	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-16.70K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-261.83K	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-239.60K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-23.25K	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.69M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.95M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.61M	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.92M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.66M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.95M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.23M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-5.62M	USD	Point-in-time
NET LOSS	`ProfitLoss`	$-5.92M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-5.61M	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.19K	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.22K	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-5.61M	USD	2 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-5.92M	USD	2 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.95M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$-2.84K	USD	2 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.69M	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.92M	USD	2 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.62M	USD	2 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.95M	USD	1 Quarter
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.22	USD	1 Quarter
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-6.51	USD	2 Qtrs
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.79	USD	1 Quarter
Net loss per share applicable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.76	USD	2 Qtrs
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	909,623.00	shares	2 Qtrs
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.76M	shares	1 Quarter
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.20M	shares	2 Qtrs
Weighted average shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	834,990.00	shares	1 Quarter

Cash Flow Statement 73 line items

Line Item	Tag	Value	Unit	Period
Interest paid in kind, related party	`PaidInKindInterestRelatedParty`	$35.55K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.23M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.62M	USD	Point-in-time
Net loss	`ProfitLoss`	$-5.92M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-5.61M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$232.72K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$141.60K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$432.76K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$757.34K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$6.42K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$9.12K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$4.63K	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$-8.63K	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-290.83K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$93.31K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-53.69K	USD	2 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-37.39K	USD	2 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$87.11K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-424.63K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$157.49K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$42.53K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-151.44K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.80M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.15M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$63.99K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.23K	USD	2 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	$36.52K	USD	2 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-63.99K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.75K	USD	2 Qtrs
Proceeds from Promissory notes (related parties $550,000)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	2 Qtrs
Proceeds from Promissory notes (related parties $550,000)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$550.00K	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$2.77M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$718.06K	USD	2 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$2.48M	USD	2 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$10.64M	USD	2 Qtrs
Repayment of convertible notes	`ProceedsFromSecuredConvertibleNotesPayable`	-	USD	2 Qtrs
Repayment of convertible notes	`ProceedsFromSecuredConvertibleNotesPayable`	$-107.80K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.30M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.75M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-118.42K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.10M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.66M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.66M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash paid during period for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid during period for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficitNonCashFinancingActivities`	$493.22K	USD	2 Qtrs
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficitNonCashFinancingActivities`	-	USD	2 Qtrs
Interest paid in kind (related party of $35,550 for the six month period ended March 31, 2019)	`PaidInKindInterest`	$35.62K	USD	2 Qtrs
Interest paid in kind (related party of $35,550 for the six month period ended March 31, 2019)	`PaidInKindInterest`	$48.82K	USD	2 Qtrs
Offering costs incurred, and included in accounts payable	`OfferingCostsIncurredAndIncludedInAccountsPayable`	-	USD	2 Qtrs
Offering costs incurred, and included in accounts payable	`OfferingCostsIncurredAndIncludedInAccountsPayable`	$15.93K	USD	2 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	-	USD	2 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$109.42K	USD	2 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	-	USD	2 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	$2.84K	USD	2 Qtrs
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	$109.70K	USD	2 Qtrs
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	-	USD	2 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	$14.38K	USD	2 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	-	USD	2 Qtrs

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-734.36K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-2.26M	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-201.22K	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-10.53M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-2.77M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-718.06K	USD	1 Quarter
Impact of adoption of new accounting pronouncements included in accumulated deficit	`ImpactOfAdoptionOfNewAccountingPronouncementsIncludedInAccumulatedDeficit`	$-493.22K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$490.24K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$267.09K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$205.49K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$227.27K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.23M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.62M	USD	Point-in-time
Net loss	`ProfitLoss`	$-5.92M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-5.61M	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$766.02K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$754.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-734.36K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.